Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP) by Niu, Jianli et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Monocyte chemotactic protein (MCP)-1 promotes angiogenesis
via a novel transcription factor, MCP-1-induced protein (MCPIP)
Citation for published version:
Niu, J, Azfer, A, Zhelyabovska, O, Fatma, S & Kolattukudy, PE 2008, 'Monocyte chemotactic protein (MCP)-
1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP)' Journal of
Biological Chemistry, vol 283, no. 21, pp. 14542-51. DOI: 10.1074/jbc.M802139200
Digital Object Identifier (DOI):
10.1074/jbc.M802139200
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Journal of Biological Chemistry
Publisher Rights Statement:
Copyright © 2008, The American Society for Biochemistry and Molecular Biology, Inc.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 28. Apr. 2017
Sumbul Fatma and Pappachan E. Kolattukudy
Jianli Niu, Asim Azfer, Olga Zhelyabovska,
  
Protein (MCPIP)
Transcription Factor, MCP-1-induced
Promotes Angiogenesis via a Novel 
Monocyte Chemotactic Protein (MCP)-1
Developmental Biology:
Molecular Basis of Cell and
doi: 10.1074/jbc.M802139200 originally published online March 24, 2008
2008, 283:14542-14551.J. Biol. Chem. 
  
 10.1074/jbc.M802139200Access the most updated version of this article at doi: 
  
.JBC Affinity SitesFind articles, minireviews, Reflections and Classics on similar topics on the 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
  
 http://www.jbc.org/content/283/21/14542.full.html#ref-list-1
This article cites 35 references, 21 of which can be accessed free at
 by guest on August 21, 2013http://www.jbc.org/Downloaded from 
Monocyte Chemotactic Protein (MCP)-1 Promotes
Angiogenesis via a Novel Transcription Factor,
MCP-1-induced Protein (MCPIP)*
Received for publication,March 18, 2008, and in revised form, March 24, 2008 Published, JBC Papers in Press,March 24, 2008, DOI 10.1074/jbc.M802139200
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From the Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida 32816
Monocyte chemotactic protein-1 (MCP-1) has been recog-
nized as an angiogenic chemokine.Themolecularmechanismof
MCP-1-mediated angiogenesis remains unknown. We recently
identified a novel transcription factor, designated MCP-1-in-
duced protein (MCPIP), in human monocytes after treatment
with MCP-1. We investigated whether MCP-1-induced angio-
genesis is mediated via MCPIP. Treatment of human umbilical
vein endothelial cells (HUVECs) with MCP-1 induced expres-
sion ofMCPIP and capillary-like tube formation. Knockdownof
MCPIP by small interfering RNA (siRNA) suppressed MCP-1-
induced angiogenesis-related gene VEGF and HIF-1 expres-
sion as well as tube formation. Transfection of HUVECs with an
MCPIP expression vector induced angiogenesis-related genes
and tube formation. Chromatin immunoprecipitation analysis
revealed that cadherin (cdh) 12 and cdh19 are in vivo targets of
MCPIP. Transfection of HUVECs with MCPIP expression vec-
tor activated the expression of cdh12 and cdh19 genes. Knock-
down of cdh12 or cdh19 expressionmarkedly inhibitedMCPIP-
induced capillary-like tube formation.Moreover, knockdown of
MCPIP also significantly suppressed MCP-1-induced cdh12
and cdh19 gene expression. Our data strongly suggest that
MCP-1-induced angiogenesis is mediated viaMCPIP, at least in
part through transcriptional activation of cdh12 and cdh19.
Angiogenesis, the formation of new blood vessels from pre-
existing vessels in adult tissue, is a key process involved in
inflammatory diseases such as diabetes, ischemic heart, and
limb diseases and tumor growth (1, 2). Although the critical
initiating event for the generation of new blood vessels has been
attributed to the production of growth factors, recruitment of
monocytes has been suggested to be important in the angio-
genic cascade (3, 4). Accumulation of leukocytes at the inflam-
matory sites is regulated by chemotactic small molecular
weight proteins called chemokines. Monocyte chemotactic
protein-1 (MCP-1),2 a key CC chemokine responsible for traf-
ficking and activation of monocytes/macrophages through its
receptor CCR2, has been implicated in inflammation and
angiogenesis (5, 6). Administration of exogenous MCP-1 has
been shown to increase monocyte/macrophage recruitment,
collateral vessel formation, and blood flow to the ischemic tis-
sue in hindlimb models of ischemia (6–8). By drilling tunnels
through myocardial tissue, monocytes/macrophages were
reported to increase angiogenesis in ischemic myocardium (9).
MCP-1 can also directly act on endothelial cells (ECs) to induce
angiogenesis (10, 11). However, the mechanisms by which
MCP-1 mediates these effects on angiogenesis are unclear.
We recently identified a novel transcription factor, desig-
nated MCP-1-induced protein (MCPIP), which was originally
found in human monocytes after treatment with MCP-1 and is
proapoptotic (12). MCP-1 induces this transcription factor,
which in turn up-regulatesmembers of the apoptotic gene fam-
ily that have been linked to angiogenesis and vascular remodel-
ing (13–15). Therefore, it appeared possible that MCP-1-in-
duced angiogenesis might be mediated by transcription factor
MCPIP. Here, we report that MCP-1 treatment of human
umbilical vein endothelial cells (HUVECs) resulted in induc-
tion of MCPIP and that expression of MCPIP enhanced endo-
thelial cell apoptosis, proliferation, migration, and expression
of angiogenesis-related genes, resulting in capillary-like tube
formation. All of these angiogenic effects ofMCP-1 and expres-
sion of MCPIP were inhibited by MCPIP-specific small inter-
fering RNA (siRNA). The chromatin immunoprecipitation
assay revealed that cadherin (cdh)12 and cdh19 were in vivo
targets of MCPIP. Knockdown of MCPIP expression signifi-
cantly reduced transcript levels of cdh12 and cdh19. Moreover,
knockdown of either cdh12 or cdh19 expression inhibited
MCPIP-induced capillary-like tube formation. These results
strongly suggest thatMCP-1-induced angiogenesis is mediated
via induction of MCPIP, the newly discovered transcription
factor, at least in part through transcriptional activation of
cdh12 and cdh19 that have not previously been implicated in
angiogenesis.
EXPERIMENTAL PROCEDURES
Cell Culture Conditions—The HUVECs (Clonetics) were
grown in endothelial cell basal medium supplemented with
hydrocortisone (1g/ml), bovine brain extract (12g/ml), gen-
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tamicin (50 g/ml), amphotericin B (50 ng/ml), epidermal
growth factor (10 ng/ml), and 2% fetal bovine serum (EGM
SingleQuots, Clonetics) as recommended by themanufacturer.
HUVECs were used between passages 4 and 8. The cell line
HEK293 was grown in Dulbeccomodified Eagle’s medium sup-
plemented with 10% fetal calf serum. All cells were maintained
at 37 °C in 5% CO2.
Plasmid Construction and Transfection—The human
MCPIP cDNA encoding the full-length MCPIP (GenBankTM
accession number: AY920403) was cloned into BamH1 and
EcoR1 sites of a pEGFP/N1 vector to generate the GFP-MCPIP
fusion protein as described previously (12). Transfection of
MCPIP plasmid in HUVECs was performed using Lipo-
fectamine PLUS Reagents (Invitrogen) with a transfection
efficiency of about 60–70%, as determined by the green
fluorescence.
Knockdown with siRNA—HUVECs, fourth generation, were
cultured in EGMBulletKitmedium (Cambrex) according to the
manufacturer’s recommendation. Human MCPIP SMART
pools designed by Dharmacon (Lafayette, CO) were delivered
into 70% confluent cells with the use of LipofectamineTM and
PLUSTM Reagents (Invitrogen) according to the manufactur-
er’s protocol. Human MCPIP siRNA SMART pools targeting
the sense sequence 5-GUAAGAAGCCACUCACUUUUU-3,
5-GCAAGCGGGUGGUGUGCUAUU-3, 5-CCAACACG-
GUGCUGGGUGAUU-3, 5-AUACUAAGCUGUGUGGUG-
UUU-3, and the antisense sequence 5-AAAGUGAGUGGC-
UUCUUACUU-3, 5-UAGCACACCACCCGCUUGCUU-3,
5-UCACCCAGCACCGUGUUGGUU-3, 5-ACACCACAC-
AGCUUAGUAUUU-3 were selected. Human cdh12 siRNA
SMART pools targeting the sense sequence 5-GAGACAAC-
GUCAUCCAUUAUU-3, 5-GGACAGCUACUUUACAAU-
AUU-3, 5-GGGCAACAAUUCUCCUUUAUU-3, 5-GCA-
GUAUAAUUUCUCCAUAUU-3, and the antisense sequence
5-UAAUGGAUGACGUUGUCUCUU-3, 5-UAUUGUAA-
AGUAGCUGUCCUU-3, 5-UAAAGGAGAAUUGUUGC-
CCUU-3, 5-UAUGGAGAAAUUAUACUGCUU-3 were
selected. Human cdh19 siRNA SMART pools targeting the
sense sequence 5-UAGGAACAAUCAUGGCAUAUU-3, 5-
GAUAAUGGUACAAUCACUAUU-3, 5-GCUGAGGAGUA-
GUACCAUAUU-3, 5-CCAGCUAAGAUCUGAUUUAUU-3
and the antisense sequence 5-UAUGCCAUGAUUGUUCCU-
AUU-3, 5-UAGUGAUUGUACCAUUAUCUU-3, 5-UAU-
GGUACUACUCCUCAGCUU-3, 5-UAAAUCAGAUCUU-
AGCUGGUU-3 were selected. HUVECs (5  104 cells/per
well) were washed with Opti-MEM I medium and incubated
with Opti-MEM I medium containing Lipofectamine/siRNA
mixture (final concentration 100 nM of siRNA) for 6 h. Then, 2
ml of fresh EBM complete medium were added, and the cells
were incubated for 24 h. To verify specificity of the knockdown
effect, we used an oligonucleotide sequence 5-UAGCGACU-
AAACACAUCAA-3 (Dharmacon) with no known mamma-
lian target as nonspecific siRNA.
Cell Migration Assays—The cell migration assay was per-
formed as described previously (16). Briefly, HUVECs (5 104
cells/per well) were seeded into 6-well plates and grown to con-
fluence. The cell monolayer was scratchedwith a plastic pipette
tip to generate a cut of 1 mm in width, and the unattached
cells were removed by washing twice. The remaining cells were
transfected with the expression vector and incubated at 37 °C,
5% CO2 for 24 h. The number of cells that had migrated across
the edge of the wound and into the denuded area was photo-
graphed and counted as migrating cells using the Metamorph
Series 6.2 image program (Universal Imaging, West Chester,
PA). Results were expressed as the average number of cells per
field of view. The experiment was repeated three times.
BrdU Incorporation Assays—To determine the effect of
MCPIP on cell proliferation, the rate of DNA synthesis was
established by measuring BrdU incorporation in control and
transfected HUVECs seeded in 8-well chamber glass slides.
After incubation for 6 hwith 10MBrdU, cells were fixed for 10
min with 3.7% paraformaldehyde and stained with an anti-
BrdU antibody (Novus) for 60 min followed by staining with
anti-rat IgG Cy2 antibody (1:500 dilution, Chemicon, Inc) for
30 min. The percentage of BrdU-positive nuclei (red) was
determined by counting five randomly selected fields under
20 magnification using theMetamorph Series 6.2 image pro-
gram. The experiment was repeated three times.
In Vitro Capillary-like Tube Formation Assays—The ability
of MCPIP to enhance HUVECs to form vascular network was
tested in a standardized in vitro angiogenesis assay. Briefly, after
transfection, HUVECswere harvested and seeded onto the sur-
face of the polymerized fibril gels (1  104 cells/per well,
Chemicon, Inc.) in 96-well plates, then incubated in EBM
medium for 24 h. Tube formation was observed under a phase
contrastmicroscope and photographed. Tube formation ability
was quantified by counting the total number of cell clusters and
branching in five randomly chosen microscopic fields per well
under100magnification. Results were expressed as themean
percentage of branching over total cell clusters and expressed as
a ratio to the control. The experimentwas repeated three times.
To examine whether MCP-1-induced angiogenic activity is
mediated via MCPIP, HUVECs were incubated in EBM
medium with the presence or absence of 100 nM of MCPIP
siRNA. Then 100 ng/ml of the recombinant human MCP-1
were added to the medium for 24 h. Capillary-like tube forma-
tion was assayed as described above.
Detection of Apoptotic Cell Death in HUVECs—HUVECs
(5 104/per well) were seeded onto 4-well chamber glass slides
and were grown to confluence. After transfection with the
MCPIP-GFP expression vector or GFP control for 24 h, cells
were fixed with 3.7% paraformaldehyde and then pretreated
with 0.1% Triton X-100 in 0.1% sodium citrate. The TUNEL
assay was performed utilizing a TMR red in situ cell death
detection kit (Roche Applied Science) per the manufacturer’s
instructions, and counterstaining of all nuclei was done with
4,6-diamidino-2-phenylindole (DAPI, Molecular Probes). The
number of TUNEL-positive cells were counted and divided by
the total number of cells in ten randomly selected fields of view
under the fluorescence microscope. The experiment was
repeated three times.
Gene Expression Profiling by Oligo GEArray Microarray—
Angiogenesis-related gene expression profiling was performed
using Oligo GEArray human angiogenesis microarray (Bio-
sciences Corp.) according to the manufacturer’s instructions.
Briefly, total RNA was isolated from HUVECs using TRIzol
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reagent (Invitrogen). The biotin UTP-labeled cDNA probes
were generated using 3 g of total RNA. The array filters were
hybridizedwith 6g of biotin-labeled probes at 60 °C overnight
in the hybridization oven. GEArray membranes were washed
and blocked with GEArray blocking solution, then incubated
with alkaline phosphatase-conjugated streptavidin, and
exposed to x-ray film (Kodak). Signal quantification of gene
expression on the array was performed with the software sup-
plied by the manufacturer.
Chromatin Immunoprecipitation (ChIP) and Gel Retarda-
tion Assays—ChIP analysis was done essentially as described
previously (17). HEK293 cells (3  107), transfected with
pEGFP/N1 or pEGFP/MCPIP vector, were treated with 1%
formaldehyde for 10 min and then lysed with lysis buffer (10
mmol/liter EDTA, 1% SDS, 1 mmol/liter phenylmethylsulfonyl
fluoride, 1 g/ml pepstatin, 1 g/ml leupeptin, 1 g/ml aproti-
nin, 50 mM Tris/HCl, pH 8.1) followed by sonication for 15 s
(Sonifire 450, Branson). The sheared preparations were incu-
bated with a rabbit polyclonal antibody against MCPIP over-
night at 4 °C. The immune complex was recovered with A/G
beads, and cross-linkingwas reversed. After removal of the pro-
tein by treatment with proteinase K, DNA was recovered by
phenol/chloroform and precipitated with sodium acetate. The
recovered DNA was cloned into
PCR-Blunt II-TOPOplasmid vector
(Invitrogen) and sequenced. The
sequences were located in the
genome data base. Genes that were
within 5 kb from the cloned
sequence were identified. The ex-
pression of these candidate genes in
HEK293 cells by transfection with
MCPIP-GFP construct compared
with GFP control was determined by
RT-PCR with the following primers:
cdh12, forward: 5-AGGAGGTGG-
GGAGGAAGATA-3, reverse: 5-
CATATGTGGCCAGTGAATCG-
3; cdh19, forward: 5-ATCTGCA-
CCCACTGGGACTT-3, reverse:
5-CTGCTCAGGAACATGATGG-
3. The cloned fragments from these
candidate genes were tested for
binding to the recombinant MCPIP
by gel retardation assays as we
described previously (18). Binding
reactions were performed in a total
volume of 25 l containing 32P-la-
beled probe, 2g of poly(dI:dC), 0.3
mg/ml acetylated bovine serum
albumin, 25 mM HEPES, pH 7.9, 80
mM KCl, 1 mM dithiothreitol, 1 mM
EDTA, 1 mM phenylmethylsulfonyl
fluoride, 10% glycerol, 0.4 g of
purifiedMCPIP protein, 2 fmol of
32P-labeled probe with or without
100- or 300-fold molar excess of
specific/nonspecific competitors.
The mixtures were incubated for 25 min at room temperature
before electrophoresis on a 4% nondenaturing polyacrylamide
gel and autoradiography of the dried gel.
RT-PCR and Real-time PCRAssays—Total RNAwas isolated
from HUVECs using TRIzol reagent. cDNA was synthesized
using the SuperScript First Strand Synthesis System (Invitro-
gen) andwas then amplified by PCRwith the following primers:
MCPIP, forward: 5-AGTCTGACGGGATCGTGGTT-3,
reverse: 5-GGGAGACGTACGGGAGTGAG-3; cdh12, for-
ward: 5-AGGAGGTGGGGAGGAAGATA-3, reverse: 5-CAT-
ATGTGGCCAGTGAATCG-3; cdh19, forward: 5-ATCTG-
CACCCACTGGGACTT-3, reverse: 5-CTGCTCAGGAAC-
ATGATGG-3; HIF-, forward: 5-TCTGGATGCTGGTGA-
TTTGG-3, reverse: 5-GTGAATGTGGCCTGTGCAGT-3;
VE Cadherin, forward: 5-GTGTTCACGCATCGGTTGTT-
3, reverse: 5-GGCTCATCTGGGTCCTCAAC-3; VEGF,
forward: 5-CCCTGGCTTTACTGCTGTAC-3, reverse: 5-
TCTGAACAAGGCTCACAGTG-3. The PCR reaction con-
sisted of 35 cycles at 94 °C for 30 s, 60 °C for 30 s, 72 °C for 30 s,
and 72 °C for 10 min. -Actin (forward: 5-AAATCGTGCGT-
GACATCAAAG-3, reverse 5-TGTAGTTTCATGGATGC-
CACAG-3) was amplified as an internal control. PCRproducts
were electrophoresed on a 1.5% agarose gel stained with
FIGURE 1. MCP-1-induced angiogenesis is mediated via induction of MCPIP. HUVECs were treated with
MCP-1with orwithout transfectionwithMCPIP-specific or nonspecific siRNA for 24 h. Expression ofMCPIPwas
detected by RT-PCR (A), real-time PCR (B), and immunoblot (C) analyses. -Actin was amplified as an internal
control for RT-PCR. D, histogram depicting the average MCPIP expression levels in the examined groups as
assessed by immunoblot analysis. E, phase-contrast photomicrographs of HUVECs treatedwithMCP-1 with or
without MCPIP-specific or nonspecific siRNA for 24 h (original magnification100), and the quantitative tube
formation assay (F). *, p 0.001 for treatment with MCP-1 and with nonspecific siRNA.
MCP-1-induced Transcription Factor in Angiogenesis
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ethidium bromide and analyzed using the imaging system
(Alphaimager 2200). To confirm the results of RT-PCR,mRNA
expression was also analyzed using iCycler real-time PCR sys-
tem (Bio-Rad) with the use of the above primers for MCPIP,
cdh12, cdh19, VE-cadherin, HIF-, and VEGF. The expression
level of each candidate gene was normalized by subtracting the
corresponding -actin threshold cycle (CT) values.
Western Blotting—HUVECs in culture under different experi-
mental conditionswere lysed, and the cell lysate was collected. An
equal amount of protein (25 g) from each condition was sub-
jected to 12.5% SDS-PAGE. Western blotting was carried out
using the indicated primary antibodies: rabbit polyclonal anti-
MCPIP antibody (12), 1:500; rabbit polyclonal anti-VE-cadherin
antibody, 1:1000; human cdh12 polyclonal antibody, 1:500 (R&D
Systems); anti-cdh19antibody, 1:2000 (Abnova), followedby incu-
bation with a horseradish peroxidase-conjugated secondary IgG.
Immunoreactive proteins were detected using an enhanced
chemiluminescence (ECL) kit (Amersham Biosciences).
StatisticalAnalysis—Data are expressed as themeanS.D. of a
given number of observations. Results were compared between
groups by one-way analysis of variance analysis followed by Stu-
dent’s t tests using SPSS 10.0 software (SPSS Inc) underWindows
XP. A p value of0.05 was considered to be significant.
RESULTS
MCP-1 Induces Up-regulation of Angiogenesis-related Genes
and in Vitro Angiogenesis via Transcription FactorMCPIP—To
investigate whether transcription factor MCPIP might be
FIGURE 2. Real-time PCR analysis of HIF- (A) and VEGF (B) expression in
HUVECs treatedwithMCP-1 with or withoutMCPIP-specific or nonspecific
siRNA. *, p 0.05 for treatment with MCP-1 and with nonspecific siRNA. #, p
0.05 versusGFP vector-transfectedHUVECs.
FIGURE 3. Expression of MCPIP induces capillary-like tube formation in
HUVECs.HUVECsweretransfectedwiththeMCPIP-GFPexpressionvectororGFP
control for 24 h, and expression ofMCPIPwas detected by real-time PCR (A) and
immunoblot (B) analyses. *, p  0.001 versus GFP vector-transfected HUVECs.
C, phase-contrast photomicrographs (original magnification 100) of HUVECs
seeded on the surface of the polymerized fibrin gels for 24 h after transfection
with MCPIP-GFP expression vector or GFP control. D, mean number of tube
branchpoints in randomly selected5highpower fields (40)of viewswasquan-
tified. *, p 0.05 versusGFP vector-transfectedHUVECs.
TABLE 1
Expression profile of angiogenesis-related genes in HUVECs
treatment with MCP-1- andMCPIP-specific siRNAMCP-1
Gene name Fold induction
a
MCP-1 siRNAMCP-1
Angiopoietin-like 3 10.0
Angiopoietin-like 4 5.0
Cadherin 5 5.0
CD13/Gp156 5.0
Chemokine (CXC motif) ligand 11 5.0 2.4
Shingolipid G-protein-coupled receptor 1 5.0 2.4
Endoglin 5.0
Laminin 5 5.1 2.1
TIMP-1 4.7
Endostatin 4.6
Prostaglandin-endoperoxide synthase 1 4.6 5.0
Akt-1 4.3 2.4
PECAM-1 4.2
Tie-1 4.2
VEGF-C 4.1
Thrombospondin-1 4.1 2.5
MMP-2 3.9 2.0
VEGF-B 3.5
ECGF-1 3.5 3.5
Chemokine (CXC motif) ligand 10 3.4 4.7
TEK tyrosine kinase 3.2 2.1
Angiopoietin 1 3.2
Platelet-derived growth factor  3.1 2.0
Collagen type IV-3 3.0
Interleukin 8 2.7
Ephrin A2 2.5
Jagged 1 2.3 2.2
Chemokine (CXC motif) ligand 2 2.2 2.4
Kinase insert domain receptor 2.1
Urokinase 2.1
Chemokine (CXC motif) ligand 1 2.0
Epidermal growth factor 2.0
a Only genes whose expression was induced at least 2.0-fold are included. Most of
angiogenesis-related genes-induced by MCP-1 were suppressed by MCPIP-specific
siRNA.
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involved in MCP-1-induced angiogenesis in endothelial cells,
we tested whether MCP-1 could induce MCPIP in HUVECs.
RT-PCR analysis revealed increased levels of MCPIP tran-
scripts in HUVECs after treatment withMCP-1 (Fig. 1A). Real-
time PCR and immunoblot analysis confirmed the up-regu-
lated expression ofMCPIP at both transcript and protein levels,
respectively (Fig. 1, B–D). Both MCPIP mRNA and protein
expression induced by MCP-1 in HUVECs were suppressed by
treatment with siRNA specific for MCPIP, but not by nonspe-
cific siRNA (Fig. 1, A–D). These results demonstrate that
MCP-1 induced expression ofMCPIP inHUVECs and effective
knockdown of MCPIP by MCPIP-specific siRNA.
We examined the potential role of MCPIP in the control of
MCP-1-induced angiogenesis using the in vitro angiogenesis
assay. HUVECs treated with MCP-1 showed significantly
increased numbers of capillary-like tube formation, and this
tube formationwas inhibited by the knockdown ofMCPIPwith
siRNA for MCPIP, whereas nonspecific siRNA showed no
effect (Fig. 1, E and F).
TheeffectsofknockdownofMCPIPontheexpressionprofileof
MCP-1-induced angiogenesis-related genes were also examined
using the Oligo GEArray human angiogenesis microarray, which
contained a total of 113 genes that are involved in modulating
angiogenesis (19–21). As summarized in Table 1, 32 of 113 genes
were up-regulated in MCP-1-treated HUVECs compared with
untreated-HUVECs (only genes
whoseexpressionwas inducedat least
2.0-fold are included). These up-reg-
ulated genes included angiopoietin-
like 3, angiopoietin-like 4, VE-cad-
herin, the VEGF family, Tie-1, ephrin
A2,MMP-1, TIMP-2, urokinase, and
chemokine ligands. The addition of
siRNA for MCPIP suppressed MCP-
1-inducedexpressionofmost of these
genes (Table 1).
MCP-1-induced angiogenesis has
been reported to be mediated
through up-regulation of hypoxia-
inducible factor-1 (HIF-1) and
subsequent induction of VEGF (11).
The findings that siRNA for
MCPIP suppressed MCP-1-in-
duced expression of VEGF (Table 1)
strongly suggest MCP-1-induced
VEGF expression is mediated via
MCPIP. Real-time PCR analysis
confirmed that MCP-1 induced
HIF-1 and VEGF production in
HUVECs and siRNA for MCPIP,
but not nonspecific siRNA, sup-
pressed the MCP-1-induced HIF-1
and VEGF expression (Fig. 2, A and
B). Furthermore, transfection of
HUVECs with MCPIP-GFP expres-
sion vector, but not GFP control,
induced HIF-1 and VEGF produc-
tion (Fig. 2,A and B).
FIGURE 4. Expression of MCPIP induces angiogenesis-related properties in HUVECs. A, confluent HUVECs
monolayerswerewoundedbyscrapingand transfectedwith theexpressionvector forMCPIP-GFPorGFPcontrol in
serum-freemedium. Cellmigration to thewound surfacewasmonitored from0 to 24h andquantitated at 24h (B).
ProliferationwasdetectedbyBrdU incorporation (C), andapoptosiswasdeterminedbyTUNEL staining (D and E) in
HUVECs transfected with expression vector for MCPIP-GFP or GFP control for 24 h. *, p 0.05 versus GFP-vector
transfectedHUVECs.
TABLE 2
Expression profile of angiogenesis-related genes in GFP/hMCPIP-
over GFP-infected HUVECs
Gene name Fold induction
Ephrin-A1 12
Interleukin 1 11.7
Notch Homolog 4 11
Ephrin B2 8.6
Platelet-derived growth factor  7.6
Tissue inhibitor of metalloproteinase 2 6.8
Ephrin A3 5.8
Midkine (neurite growth promoting factor 2) 5.1
Thrombospondin 1 5
Colony-stimulating factor 3 5
Angioprotein 2 4.4
Chemokine (CXC motifs) ligand 9 4.3
Angiogenic factor with path and FHA domains 4
Matrix metalloproteinase 9 3.8
Hypoxia-inducible factor 1 3.6
Chemokine (CXC motifs) ligand 2 3.5
Chemokine (CXC motifs) ligand 3 3.4
Chemokine (C-C motif) ligand 11 3.2
Epidermal growth factor 3.2
Neuropilin 1 3.1
Collagen type IV 3 2.6
Angioprotein 1 2.5
Tumor necrosis factor superfamily 12A 2.5
Chemokine (CXC motifs) ligand 5 2.5
Chemokine (C-C motif) ligand 2 2.5
Chemokine (CXC motifs) ligand 1 2.4
Angioprotein-like 4 2.4
Urokinase 2.2
VEGF 2.0
Interleukin 8 2.0
Jagged 1 2.0
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Expression of MCPIP Up-regulates Angiogenesis-related
Genes and Promotes Capillary-like Tube Formation by
HUVECs—Wenext examinedwhether expression ofMCPIP in
HUVECs directly up-regulates angiogenesis-related genes and
induces angiogenesis. When HUVECs were transfected with
MCPIP-GFP vector, the increased expression of MCPIP was
found after 24 h at both mRNA and protein levels as measured
by real-timePCR and immunoblot analyses, respectively (Fig. 3,
A and B). When RNA harvested from GFP- or MCPIP-GFP-
expressing HUVECs was subjected to angiogenesis gene array
analysis, we observed that MCPIP induced up-regulation of 31
of 113 genes that are known to contribute to the increased
angiogenic properties of endothelial cells (Table 2). These up-
regulated genes included ephrin A1, ephrin B2, ephrin A3,
IL-1, notch homolog 4, angiopoietin-2, neuropilin-1, uroki-
nase, PDGF-, TIMP-2, MMP-9, and chemokine ligands.
WhenHUVECs transfectedwithMCPIPwere planted onto the
surface of the polymerized fibrin gels for 24 h, we observed the
typical capillary-like tube formation, whereas no significant
angiogenic responses were observed in HUVECs transfected
with theGFP expression control plasmid (Fig. 3C).Quantitative
analysis of tube formation showed that tube formation in
HUVECs transfected with MCPIP-GFP was much higher than
that observed with GFP control (Fig. 3D). These results suggest
that expression of MCPIP can directly induce endothelial cell
capillary-like tube formation.
Influence ofMCPIP on Endothelial Cell Behavior—Capillary-
like tube formation in fibrin gels depends on the migratory and
proliferative potential of endothelial cells. This process begins
with the formation of endothelial cell sprouts initiated by apo-
ptosis, followed by the proliferation andmigration of neighbor-
ing endothelial cells along preformed extensions (15, 22). As
MCPIP can induce capillary-like tube formation, we tested
whether MCPIP might enhance angiogenesis-related proper-
ties of HUVECs. After 24 h of incubation, HUVECs transfected
with MCPIP-GFP displayed significantly increased cell migra-
tion comparedwith cells transfectedwithGFP control (Fig. 4,A
and B). DNA synthesis, as determined by BrdU incorporation,
was also compared in HUVECs transfected with MCPIP-GFP
or the GFP control. Results showed that MCPIP caused
increased DNA synthesis (Fig. 4C). TUNEL assay and DAPI
counterstaining were performed to detect apoptotic cell death
in HUVECs after transfection with MCPIP-GFP expression
vector or GFP control. After 24 h, HUVECs transfected with
MCPIP-GFP showed a higher number of TUNEL-positive cells
compared with cells transfected with the GFP control (Fig. 4,D
and E). These results indicate that expression of MCPIP causes
the induction of angiogenesis-related properties of HUVECs.
FIGURE 5. Induction of cdh12 and cdh19byMCPIP and specific binding of
MCPIP to cdh12 and cdh19. A, HEK293 cells were transfected with the
MCPIP-GFP expression vector or GFP control for 12 h. RNA was isolated and
subjected to RT-PCR using primers for cdh12 and cdh19 sequences. -Actin
was amplified as an internal control. B and C, gel retardation assays were
performed as described under “Experimental Procedures” with a 32P-labeled
415-bp cdh12 gene fragment and a 207-bp cdh19 fragment with or without
the indicated excess of unlabeled specific gene fragment or nonspecific DNA.
FIGURE 6.MCPIP induces cdh12 and cdh19 expression inHUVECs.A and B,
HUVECs were transfected with MCPIP-GFP expression vector or GFP control
for 24 h, and expression of cdh12 and cdh19 was detected by real-time PCR.
The expression of both cdh12 and cdh19 at protein levels was demonstrated
by immunoblot analysis (C and D). VE-cadherin, an endothelial cell-specific
cadherin required for angiogenesis,was also found tobe inducedbyMCPIP at
both transcript and protein levels, assayed by real-time PCR (E) and Western
blot (F). *, p 0.05 versus GFP vector-transfected HUVECs.
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cdh12 and cdh19 Are in Vivo Targets of MCPIP—To identify
the potential in vivo target genes for MCPIP, ChIP assays were
performed in HEK293 cells transfected with the MCPIP-GFP
expression vector. Sequencing of the MCPIP-bound genomic
fragments revealed binding to cdh12 and cdh19 genes, indicating
that these are in vivo targets ofMCPIP. Because in vivo binding of
a protein toDNA segments in the genomewithout affecting tran-
scription ispossible,we testedwhetherMCPIPexpressionup-reg-
ulates the expression of cdh12 and cdh19 genes. The transcript
levels of cdh12 and cdh19 were elevated in HEK293 cells trans-
fected with the MCPIP-GFP expression vector compared with
cells transfected with the GFP control (Fig. 5A). Furthermore, gel
retardation assays showed that the cloned fragments from cdh12
and cdh19 genes, where in vivo binding of MCPIP in the
genome was indicated by the ChIP analysis, bound to recom-
binant MCPIP protein (Fig. 5, B and C). This binding was
competed out by an excess of unla-
beled specific gene fragments, but
not by nonspecific DNA, demon-
strating that this MCPIP binding
was DNA sequence-specific. These
results strongly suggest that cdh12 and
cdh19 are in vivo targets ofMCPIP.
Contribution of cdh12 and cdh19
to MCPIP-induced Angiogenesis in
Vitro—As cadherins have been
shown to play a central role in the
initiation of cellular response and
the assembly of the vascular net-
work (23), we tested whether
MCPIP-mediated induction of
cdh12 and cdh19might be involved
in MCPIP-induced angiogenesis by
HUVECs. Real-time PCR analysis
showed that expression of cdh12
and cdh19 were induced in
HUVECs after transfection with
MCPIP-GFP expression vector
compared with cells transfected
with the GFP control (Fig. 6, A and
B), and the induction of cdh12 and
cdh19 by protein expression was
further confirmed by immunoblot
analysis (Fig. 6,C andD), suggesting
that MCPIP indeed up-regulated
expression of cdh12 and cdh19
in HUVECs. Vascular endothelial
(VE)-cadherin, an endothelial cell-
specific cadherin required for
angiogenesis, was also found to be
induced by MCPIP at both tran-
script and protein levels (Fig. 6, E
and F). siRNA specific for cdh12
and cdh19 markedly suppressed
MCPIP-induced expression of
cdh12 and cdh19 at both transcript
and protein levels (Fig. 7, A–D).
Specificity of knockdown was indi-
cated by the real-time PCR analysis showing that siRNA for
cdh12 did not affect the transcription of cdh19, and siRNA for
cdh19 did not affect the transcription of cdh12 (Fig. 7,A and B).
However, the levels of both cdh12 and cdh19 proteins
decreased in HUVECs by siRNA specific for either cdh12 or
cdh19 (Fig. 7, C and D). Knockdown of both cdh12 and cdh19
drastically diminished the levels of both cdh12 and cdh19 pro-
teins induced by enhanced expression of MCPIP (Fig. 7, C and
D). Thus, it is possible that siRNA for cdh12 and cdh19 not
only affect transcription of their respective genes, but also
translation of mRNA for both cdh12 and cdh19. siRNA spe-
cific for either cdh12 or cdh19 significantly inhibited
MCPIP-induced capillary-like tube formation in vitro, and
knockdown of both cdh12 and cdh19 by siRNA showed
enhanced inhibition of MCPIP-induced cdh12 and cdh19
expression and capillary-like tube formation (Fig. 7, E and F).
FIGURE 7. Contribution of cdh12 and cdh19 expression to MCPIP-mediated angiogenesis. A and B, real-
time PCR analysis of cdh12 and cdh19mRNA in HUVECs transfected with the expression vector for MCPIP-GFP
with or without cdh12- and cdh19-specific or nonspecific siRNA showed that only siRNA specific for the partic-
ular cdh gene showed knockdown. *, p 0.05 versusMCPIP vector-transfected HUVECs. C and D, histograms
depicting the average cdh12 and cdh19 expression levels in the examined groups shown in the Western blot.
Lane 1, GFP; lane 2, MCPIP; lane 3, MCPIPcdh12 siRNA; lane 4, MCPIPcdh19 siRNA; lane 5, MCPIPcdh12,19
siRNA. *, p 0.05; #, p 0.01 versus MCPIP vector-transfected HUVECs. E, phase-contrast photomicrographs
(original magnification 100) of HUVECs seeded on the surface of the polymerized fibrin gels for 24 h after
transfectionwithMCPIP expression vector,MCPIPcdh12 siRNA,MCPIPcdh19 siRNA, orMCPIPcdh12, 19 siRNA.
F,meannumberof tubebranchpoints in randomlyselected5high-power field (100)ofviewswerequantifiedand
expressed as a percentage ofMCPIP-treated group; *, p 0.05 versusMCPIP vector-transfectedHUVECs.
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We next examined whether MCP-1 induces expression of
cdh12 and cdh19 in HUVECs during the development of tube
formation. Real-time PCR and immunoblot analysis revealed a
significant increase in cdh12 and cdh19 at transcripts and pro-
tein levels inHUVECs after treatmentwithMCP-1 for 24 h, and
these increases were markedly suppressed by treatment with
siRNA specific for MCPIP but not nonspecific siRNA (Fig. 8,
A–D), suggesting that MCP-1-induced angiogenesis is associ-
ated with MCPIP-mediated induction of cdh12 and cdh19.
DISCUSSION
MCP-1 is known to facilitate angiogenesis (6, 7, 9–11). How-
ever, themechanism by whichMCP-1mediates angiogenesis is
unknown. Here we report that MCPIP, a novel transcription
factor induced by MCP-1 in human peripheral blood mono-
cytes (12), is also induced by MCP-1 in HUVECs and that this
transcription factor mediates angiogenesis induced by MCP-1.
Our study identified cdh12 and cdh19 as in vivo targets of
MCPIP. Knockdown of MCPIP significantly suppressed MCP-
1-induced expression of cdh12 and cdh19 in HUVECs. More-
over, knockdown of either cdh12 or cdh19 with specific siRNA
inhibited MCPIP-induced angiogenesis. These findings
strongly suggest MCP-1-induced angiogenesis is mediated via
MCPIP, at least in part through
transcriptional activation of cdh12
and cdh19.
Angiogenesis is a complex proc-
ess that involves the activation of
quiescent endothelial cells to the
migratory and proliferative phe-
notype, and differentiation to
the angiogenic phenotype (22).
Recently, apoptosis of endothelial
cells has been implicated in the ini-
tiation of angiogenesis and in the
regression of neo-vessels (13–15).
Several reports suggest thatMCP-1-
induced angiogenesis ismediated by
monocyte chemotaxis (6–9) or
through pathways involving VEGF
and activation of RhoA small G pro-
tein (10, 11). MCPIP was initially
identified as a transcription factor
induced by MCP-1 in monocytes
and it was shown to have a proapo-
ptotic activity (12, 24). In the pres-
ent study we demonstrate that
MCPIP expression in HUVECs
promotes cell proliferation and
migration. The MCPIP-induced
angiogenesis was found to be
accompanied by induction of apo-
ptotic cell death and the disap-
pearance of the endothelial cell
monolayer. WhenMCPIP-specific
siRNA was added to HUVECs
treated with MCP-1, they signifi-
cantly inhibited the MCP-1-medi-
ated angiogenesis, demonstrating the angiogenic activity of
MCPIP.
Endothelial cells express a variety of genes during vascular
development or angiogenesis (19–21). Thus, our discovery
of MCPIP as a novel angiogenic factor prompted us to exam-
ine whether MCPIP plays a key role in MCP-1-induced
expression of genes potentially involved in angiogenesis.
Consistent with a role in endothelial sprouting and tube for-
mation, many of the genes identified to be up-regulated by
MCP-1 included molecules associated with cell communica-
tion and morphogenesis. These genes include the growth
factors and receptors (angiopoietin-1, angiopoietin-like 3,
angiopoietin-like 4, PDGF-, VEGF, ECGF, EphA2), cyto-
kines and chemokines (CXCL-1, CXCL-2, CXCL-10, and
IL-8), adhesion molecules and matrix proteins (VE-cad-
herin, collagen type IV-3, and laminin 5) as well as pro-
teases and their inhibitors (MMP-2,TIMP-1, and urokinase).
Such genes are now recognized to modulate the biochemical
processes involved in angiogenesis (19–21). For example,
angiopoietin-1 plays an essential role in regulating angiogen-
esis (25). Angiopoietin-like 3 and -4 are both agonists of the
Tie2 receptor whose signaling is critical to regulating vascu-
lar stabilization and remodeling (25). EphA2 was reported to
FIGURE 8. MCP-1 treatment induces expression of cdh12 and cdh19 in HUVECs and siRNA specific for
MCPIP inhibits their expression. A and B, HUVECs were treated with MCP-1 (100 ng/ml), in the presence or
absence of MCPIP-specific or nonspecific siRNA for 24 h, and mRNA expression of cdh12 and cdh19 was
assessed by real time-PCR demonstrating that knockdown of MCPIP inhibited MCP-1 induced expression of
cdh12 and cdh19. *, p 0.05 versusMCP-1- or nonspecific siRNA-treated HUVECs. -Actin was amplified as an
internal control.C andD, histogramsdepicting the average cdh12 and cdh19 expression levels in the examined
groups shown in the Western blot. Lane 1, control; lane 2, MCP-1; lane 3, MCP-1nonspecific siRNA; lane 4,
MCP-1MCPIP siRNA. *, p  0.05 versus MCP-1-treated HUVECs or MCP-1 with nonspecific siRNA-treated
HUVECs.
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be important in regulating endothelial cell assembly and
migration through phosphoinositide 3-kinase-mediated
activation of Rac1 GTPase (26). Similarly, inflammatory che-
mokine IL-8 has been shown to have proangiogenic activity
(27). To test whether these up-regulated genes induced by
MCP-1 are mediated via MCPIP, RNA interference experi-
ments were performed. Microarray analysis revealed that
expression of most of these up-regulated genes was signifi-
cantly suppressed by siRNA specific for MCPIP. Further-
more, we demonstrated that transfection of MCPIP in
HUVECs with an MCPIP expression vector resulted in up-
regulation of angiogenesis-related genes. Up-regulation of
EphA3, EphB2, IL-1, and notch homolog 4 by MCPIP that
we observed, fit well with recent findings demonstrating
coordinated participation of these gene products in angio-
genesis (28–31).
Cadherins are commonly activated by vascular remodel-
ing-related molecules and play a central role in the initiation
of cellular response and the assemblies of the vascular net-
work (23). ECs express two major cadherins, VE- and N-cad-
herins. The importance of VE-cadherin in vascular develop-
ment has been well established (32), whereas N-cadherin is
thought to function in adherence junctions between endo-
thelial cells and mural cells (pericytes and vascular smooth
muscle cells) (33). Although N-cadherin has been known to
be abundantly expressed in endothelial cells (34), its role in
endothelial cell function, including angiogenesis, has
remained largely elusive. Recently, N-cadherin has been
found to play a fundamental role in angiogenesis by modu-
lating adherence junction components and EC behavior (35).
The endothelial-specific knockout of N-cadherin in mice led
to an aberrant vasculature both in the embryo and in the yolk
sac, resulting in embryonic lethality at mid-gestation (35).
Prior to the present study, there had been no previous doc-
umentation of involvement of cdh12 and cdh19 (both belong
to N-cadherin family) in endothelial sprouting or angiogen-
esis. The ChIP assay, the widely used approach to identify the
in vivo targets of transcription factors, revealed that cdh12
and cdh19 are in vivo targets ofMCPIP in HEK293 cells. That
cdh12 and cdh19 are the targets of MCPIP in HUVECs was
shown by the induction of these genes through expression of
MCPIP that also caused capillary-like tube formation. The
inductions of cdh12 and cdh19 and tube formation were sup-
pressed by knockdown of MCPIP with specific siRNA. Fur-
thermore, down-regulation of cdh12 and cdh19 by specific
siRNA significantly attenuated the capillary-like tube forma-
tion induced by the expression of MCPIP. These observa-
tions strongly suggest that MCPIP promotes angiogenesis at
least in part via enhanced expression of cdh12 and cdh19.
Further studies will be required to fully understand the
newly discovered role of cdh12 and cdh19 in the regulation of
angiogenesis.
MCP-1-induced angiogenesis has been reported to be medi-
ated through up-regulation of HIF-1 and subsequent induc-
tion of VEGF (11). In the present study, the Oligo GEArray
microarray showed up-regulation of HIF-1 (3.6-fold) in
HUVECs transfected with the MCPIP-GFP expression vector
over GFP control, and knockdown of MCPIP prevented this
HIF-1 induction. A significant induction of VEGF was also
observed in HUVECs treated with MCP-1 or transfected with
theMCPIP-GFP expression vector. KnockdownofMCPIPwith
specific siRNA suppressed MCP-1-induced VEGF expression,
suggesting that MCP-1-induced up-regulation of HIF-1 and
induction of VEGF are mediated through the transcription fac-
tor MCPIP.
In conclusion, we have demonstrated that transcription fac-
torMCPIP regulates the expression of cdh12 and cdh19 and is a
modulator of angiogenesis. The present studies provide new
insights into the mechanism by which MCP-1 induces angio-
genesis. In future studies, however, it will be important to ascer-
tain whether MCPIP actually accelerates angiogenesis in vivo.
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